查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2056450

靜脈注射Ibuprofen市場報告：按產品劑量、適應症、年齡層和地區分類（2026-2034 年）

Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2025年全球靜脈注射Ibuprofen市場規模達78億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到136億美元，2026年至2034年的複合年成長率為6.20%。

Ibuprofen是非類固醇消炎劑(NSAID)，用於治療發炎、疼痛和發熱。它透過抑制Cyclooxygenase(COX-1 和 COX-2) 來發揮作用，而環氧合酶是合成前列腺素 (PG) 所必需的。靜脈注射Ibuprofen可單獨使用或與其他藥物合併使用，以緩解輕度至重度不適。它直接注射到靜脈，抑制體內某些引起發炎的天然物質的產生。布洛芬安全性良好，有助於減少對鴉片類止痛藥的需求，並降低疼痛程度。靜脈注射Ibuprofen也有助於改善整形外科和腹部手術期間的疼痛管理、退燒，並減少鴉片類藥物的使用。

靜脈注射Ibuprofen市場趨勢：

全球老年人口的持續成長，以及關節炎、心血管疾病和癌症盛行率的上升，為市場創造了良好的前景。因此，該產品在發炎性疾病、風濕性疾病、輕度至中度疼痛、發燒、月經和骨關節炎的治療和管理方面的應用日益廣泛，推動了市場成長。此外，繁忙的工作安排、不健康的生活方式以及由此導致的體力活動減少和營養不良，也加劇了慢性病的發生率，這也是推動市場成長的因素之一。

此外，該產品在治療兒童輕度發燒、牙痛、胃腸道疼痛和開放性動脈導管的應用日益廣泛，也推動了市場成長。同時，靜脈注射Ibuprofen用於緩解肌肉疼痛、風濕痛、背痛、神經痛、扭傷、肌肉拉傷、運動傷害和肌肉骨骼疾病，也促進了市場成長。

此外，整形外科患者（尤其是接受膝關節或髖關節置換術的患者）對靜脈注射Ibuprofen的需求不斷成長，以減輕疼痛並減少氫可酮的使用，這對市場成長產生了積極影響。預計推動市場成長的其他因素包括醫療基礎設施的顯著改善、個人健康意識的提高以及消費者購買力的增強。

本報告解答的主要問題

  • 2025年全球靜脈注射Ibuprofen市場規模有多大？
  • 2026年至2034年全球靜脈注射Ibuprofen市場的預期成長率為何？
  • 推動全球靜脈注射Ibuprofen市場發展的主要因素是什麼？
  • 新冠疫情對全球靜脈注射Ibuprofen市場產生了哪些影響？
  • 全球靜脈注射Ibuprofen市場依適應症分類的詳細情形如何？
  • 全球靜脈注射Ibuprofen市場依年齡層分類的情況如何？
  • 全球靜脈注射Ibuprofen市場的主要地區有哪些？
  • 全球靜脈注射Ibuprofen市場的主要參與者/公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球靜脈注射Ibuprofen市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品劑量分類

  • 100毫克劑量
  • 200毫克劑量
  • 400毫克劑量
  • 800毫克劑量

第7章 市場區隔：依適應症分類

  • 疼痛/炎症
  • 發燒

第8章 市場區隔：依年齡層別分類

  • 兒童
  • 成人

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
Product Code: SR112026A6440

The global intravenous (IV) ibuprofen market size reached USD 7.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.20% during 2026-2034.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor.

Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth.

Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

The research provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on product dose, indication and age group.

Breakup by Product Dose:

  • 100 Mg Dose
  • 200 Mg Dose
  • 400 Mg Dose
  • 800 Mg Dos.

Breakup by Indication:

  • Pain/Inflammatory
  • Feve.

Breakup by Age Group:

  • Pediatrics
  • Adult.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Afric.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • What was the size of the global Intravenous (IV) ibuprofen market in 2025?
  • What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2026-2034?
  • What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • What are the key regions in the global Intravenous (IV) ibuprofen market?
  • Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Sales Value (in Billion USD), 2020-2025
  • Figure 2: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 3: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2025
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2025
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2025
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 9: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: North America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: United States: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Canada: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: China: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Japan: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: India: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Australia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Europe: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Germany: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: France: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Italy: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Spain: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Russia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2025
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 73: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million USD), 2026-2034
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million USD), 2026-2034
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players